Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects
Call us @: 844 663-3742
Study Details
Medical Condition
Study Phase
Intervention Type
Date
Participation Requirements
Gender
Age
Healthy Volunteers
Inclusion Criteria
Exclusion Criteria
Have a question?
You can ask us questions via online form or phone call.
Call us @: 844 663-3742
| Location | Status | Site Contact Details |
|---|---|---|
Location Newark, New Jersey | Status Not Available | |
Location Montreal, Quebec | Status Not Available |
Efficacy and safety evaluation of Combigan with timolol when each is used as adjunctive therapy to Xalatan in subjects with glaucoma or ocular hypertension.
Mean Intraocular Pressure (IOP) at 10 AM at Week 12
Time Frame: Week 12
Mean Intraocular Pressure (IOP) at 10 AM at Week 6
Time Frame: Week 6
Mean Intraocular Pressure (IOP) at 8 AM at Week 12
Time Frame: Week 12
Mean Intraocular Pressure (IOP) at 8 AM at Week 6
Time Frame: Week 6
Number of Subjects With Adverse Events
Time Frame: Week 12
Interventions:
- Drug: Fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5%
- Drug: timolol maleate 0.5%
- Drug: latanoprost 0.005%
- Drug: latanoprost 0.005%
Enrollment:
204
Additional Information
Watch a video to learn more about what you may experience as a clinical trial volunteer: /resources/what-happens-in-a-clinical-trial
Take a virtual reality screening visit tour to an example of a clinical trial site: /resources/screening-visit-virtual-tour
Use a questionnaire tool to think through questions to ask yourself about participating in a clinical trial and print out your responses to discuss with your partners in your health journey: /resource-information-clinical-trial-community/decision-counselor